Recalling firm
Boothwyn Pharmacy LLC
Product type
Drug
Status
Ongoing
Report date
2025-09-10
Distribution
U.S. Nationwide
Firm state
PA
Product quantity
648 vials
Initiated by
Voluntary: Firm initiated
SPEQ quality domain
Validation & QualificationReason for recall
Subpotent Drug
Product description
Semaglutide, 2.5 mg/mL injection, 4 mL, Boothwyn Pharmacy
Code / lot info
03202025@2, 03202025@3 and 03202025@4 BUD 07/18/2025
Other recalls SPEQ maps to Validation & Qualification
See all Validation & Qualification recalls →Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.